Global burden of liver disease: 2023 update
Liver disease accounts for two million deaths annually and is responsible for 4% of all
deaths (1 out of every 25 deaths worldwide); approximately two-thirds of all liver-related …
deaths (1 out of every 25 deaths worldwide); approximately two-thirds of all liver-related …
Drug-induced liver injury
RJ Andrade, N Chalasani, ES Björnsson… - Nature Reviews …, 2019 - nature.com
Drug-induced liver injury (DILI) is an adverse reaction to drugs or other xenobiotics that
occurs either as a predictable event when an individual is exposed to toxic doses of some …
occurs either as a predictable event when an individual is exposed to toxic doses of some …
Drug induced liver injury: an update
M Garcia-Cortes, M Robles-Diaz, C Stephens… - Archives of …, 2020 - Springer
Drug induced liver injury (DILI) is a relatively rare hepatic condition in response to the use of
medications, illegal drugs, herbal products or dietary supplements. It occurs in susceptible …
medications, illegal drugs, herbal products or dietary supplements. It occurs in susceptible …
EASL clinical practice guidelines: drug-induced liver injury
Idiosyncratic (unpredictable) drug-induced liver injury is one of the most challenging liver
disorders faced by hepatologists, because of the myriad of drugs used in clinical practice …
disorders faced by hepatologists, because of the myriad of drugs used in clinical practice …
EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure
The term acute liver failure (ALF) is frequently applied as a generic expression to describe
patients presenting with or developing an acute episode of liver dysfunction. In the context of …
patients presenting with or developing an acute episode of liver dysfunction. In the context of …
Drug-induced liver injury: Asia Pacific Association of Study of Liver consensus guidelines
Idiosyncratic drug-induced liver injury mimics acute and chronic liver disease. It is under
recognized and underrecognised because of the lack of pathognomonic diagnostic …
recognized and underrecognised because of the lack of pathognomonic diagnostic …
Acetaminophen (APAP) hepatotoxicity—isn't it time for APAP to go away?
WM Lee - Journal of hepatology, 2017 - Elsevier
Acetaminophen (APAP) is the most commonly used drug for the treatment of pain and fever
around the world. At the same time, APAP can cause dose-related hepatocellular necrosis …
around the world. At the same time, APAP can cause dose-related hepatocellular necrosis …
Acute liver failure
W Bernal, J Wendon - New England Journal of Medicine, 2013 - Mass Medical Soc
Acute Liver Failure | New England Journal of Medicine Skip to main content The New England
Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES Cardiology Clinical …
Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES Cardiology Clinical …
Incidence and risk factors of drug‐induced liver injury
X Li, J Tang, Y Mao - Liver International, 2022 - Wiley Online Library
The epidemiology and aetiology of drug‐induced liver injury (DILI) vary across different
countries and populations. Overall, DILI is rare in the general population but has become …
countries and populations. Overall, DILI is rare in the general population but has become …
Extracellular HMGB1 as a therapeutic target in inflammatory diseases
U Andersson, H Yang, H Harris - Expert opinion on therapeutic …, 2018 - Taylor & Francis
Introduction: High-mobility group box 1 (HMGB1) is a ubiquitous nuclear protein that
promotes inflammation when released extracellularly after cellular activation, stress …
promotes inflammation when released extracellularly after cellular activation, stress …